Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar;6(1):1-16.
doi: 10.1007/s40501-019-0164-6. Epub 2019 Jan 31.

Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis

Affiliations

Multidisciplinary Treatment for Individuals at Clinical High Risk of Developing Psychosis

Jean Addington et al. Curr Treat Options Psychiatry. 2019 Mar.

Abstract

Purpose: One of the goals of identifying youth identified, based on clinical symptoms, as being at risk for developing psychosis, is to find ways to prevent or even delay the onset of the illness. Over the past 20 years, relatively few randomized control trials (RCTs), including both pharmacological and psychosocial interventions, have been conducted and often with inconsistent results. Several recent meta-analyses suggest that there are few treatments if any that might be effective and that no one treatment is seen as being more effective than any other treatment. This review aims to examine the existing RCTs and to critically review recent meta-analyses.

Recent findings: Individuals at clinical high risk for psychosis are a heterogenous group. Unfortunately, many interventions have not been specifically designed to address the outcome being assessed nor have participants been specifically selected for that treatment.

Summary: The trials completed to date and the recent systematic reviews should be seen positively and used to guide the design of future trials to ensure that the right interventions are offered to the right people at the right time.

Keywords: clinical high risk; clinical trials; meta-analyses; prodrome; psychosis; treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Jean Addington, Daniel Devoe and Olga Santesteban-Echarri declare that they have no conflict of interest.

Figures

Figure 1.
Figure 1.
Published CHR research studies versus published CHR treatment studies (1990-2018)

References

    1. McGlashan T, Walsh B, Woods S. The psychosis-risk syndrome: handbook for diagnosis and follow-up. Oxford University Press; 2010.
    1. Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M et al. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. The Australian and New Zealand journal of psychiatry. 2005;39(11-12):964–71. doi:10.1080/j.1440-1614.2005.01714.x. - DOI - PubMed
    1. Schultze-Lutter F, Addington J, Ruhrmann S, Klosterkötter J. Schizophrenia proneness instrument, adult version (SPI-A). Rome, Italy; Giovanni Fiorito Editore: 2007.
    1. Morrison AP, Fench P, Walford L, Lewis SW, Kilcommons A, Green J et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk. Randomised controlled trial. British Journal of Psychiatry. 2004;185:291–7. - PubMed
    1. Morrison AP, French P, Stewart SLK, Birchwood M, Fowler D, Gumley AI et al. Early detection and intervention evaluation for people at risk of psychosis: Multisite randomised controlled trial. BMJ. 2012;344:1–14. - PMC - PubMed

LinkOut - more resources